Peptide record

TPDB45118

Antiviral standard
53 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45118
Antiviral
Anti-infective peptides
AVPpred-BWR
standard
No
A 53-aa standard-residue antiviral peptide sequence curated from AVPpred-BWR, with an available 3D structural model.
Sequence
GEPIINFYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDELLHNVNAGKSTT
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C264H408N68O86
CMW
S
5910.55
4.29
5
8
20
-4
1.75
-0.342
88.30
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1490
0.25
16
Residue Composition
number
3
A
1
R
5
N
4
D
0
C
4
E
2
Q
2
G
1
H
5
I
4
L
3
K
0
M
4
F
3
P
6
S
2
T
0
W
1
Y
3
V
Amino Acid Distribution
A: 3 R: 1 N: 5 D: 4 C: 0 E: 4 Q: 2 G: 2 H: 1 I: 5 L: 4 K: 3 M: 0 F: 4 P: 3 S: 6 T: 2 W: 0 Y: 1 V: 3
Chemical Descriptors
53 reviewed residue count
C264H408N68O86 sequence-only estimate (linear, free termini)
5910.55 sequence-only estimate (linear, free termini)
4.29 sequence-only estimate (linear, free termini)
-4 sequence-only estimate (linear, free termini)
1.75 sequence-only estimate (linear, free termini)
-0.342 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA